ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

RFPs Go Out To Cooperative Groups for Community Programs

April 9, 1976

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

Cancer Program Progress Detailed

March 5, 1976

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976